Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated metadata shows a new revision label (v3.4.2) and added dates (2026-02-05, 2026-12, 2026-01-16, 2026-01). Older notices including the government funding lapse message and the previous revision (v3.4.1) were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide funding/status notice indicating government funding impacts and updated the page revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedA glossary toggle was added and several metadata/versioning fields were updated or renamed (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), with the previous QC wording and No FEAR Act data removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 updated from v3.3.3; no visible changes to study details or site functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedDifference2%

- Check92 days agoChange DetectedPublication note wording changed to indicate publications are automatically filled from PubMed, and the Revision tag was updated to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.